期刊文献+

儿童结节性硬化症合并室管膜下结节或室管膜下巨细胞星形细胞瘤的治疗体会 被引量:4

Experience in the treatment of tuberous sclerosis complex with subependymal nodule/subependymal giant cell astrocytoma
原文传递
导出
摘要 目的 探讨儿童结节性硬化症(TSC)合并室管膜下结节(SEN)或室管膜下巨细胞星形细胞瘤(SEGA)的治疗方案和预后.方法 采用病例系列回顾性研究方法分析2010年4月至2019年3月首都医科大学附属北京儿童医院神经外科收治的12例TSC合并SEN或SEGA患儿的临床资料.所有患儿的影像学均表现为孟氏孔附近的占位性病变特征.12例患儿中,6例考虑为SEN,未行治疗或行药物治疗;6例患儿考虑为SEGA,除1例放弃治疗外,另5例均予肿瘤切除,其中4例采用经额叶皮质造瘘入路,1例采用经胼胝体-穹窿间入路.6例患儿应用哺乳动物雷帕霉素靶蛋白抑制剂西罗莫司治疗.通过临床随访和影像学随访评估患儿的预后.结果 5例行手术治疗的患儿均达到肿瘤全切除,病理学结果提示均为SEGA(世界卫生组织分级为Ⅰ级).1例患儿术后发生脑积水,予脑室-腹腔分流术.12例患儿的随访时间为0.5 ~9.0年.5例患儿术后均无神经功能障碍,至末次随访无复发.6例SEN患儿行影像学复查提示SEN未见增大.6例应用西罗莫司的患儿癫痫发作次数均减少了50%以上.结论 儿童TSC合并SEN或SEGA临床鲜见,针对个体情况制定诊疗计划,可获得较好的临床结局,但患儿的远期预后情况仍需随访. Objective To explore the treatment regimen and outcome of tuberous sclerosis complex(TSC)with subependymal nodule(SEN)/subependymal giant cell astrocytoma(SEGA).Methods The clinical data of 12 children with TSC with SEN/SEGA admitted to Department of Neurosurgery,Beijing Children′s Hospital Affiliated to Capital Medical University from April 2010 to March 2019 were retrospectively analyzed in this case-series study.The imaging findings in 12 cases showed typical space-occupying lesions in the vicinity of the foramen mencius.Among them,6 cases that were considered as SEN underwent no surgical treatment,and out of the other 6 cases considered as SEGA,5 cases underwent tumor resection(through the approach of frontal cortex fistula in 4 and the transcallosal interforniceal approach in 1)and 1 case refused treatment.The mammalian target of rapamycin(mTOR)inhibitor sirolimus was used in 6 cases.The outcomes of those children were evaluated by outpatient clinical and imaging follow-up.Results All 5 children undergoing surgery achieved total resection of the tumor and pathological results indicated SEGA(World Health Organization gradeⅠ).One case developed hydrocephalus after surgery and then underwent ventriculoperitoneal shunting.The follow-up period of 12 children was 0.5-9.0 years.None of the 5 patients had neurological dysfunction or recurrence at the latest follow-up.Imaging examination of 6 children with SEN showed no enlargement of SEN.The frequency of seizures was reduced by more than 50%in all 6 children treated with sirolimus.Conclusions Children with TSC combined with SEN/SEGA are rare.Individualized diagnosis and treatment plan could lead to relatively good clinical outcomes,while further follow-up is still needed for the study of the children’s long-term outcome.
作者 赵凤毛 葛明 冀园琦 孙骇浪 张楠 曾津津 Zhao Fengmao;Ge Ming;Ji Yuanqi;Sun Hailang;Zhang Nan;Zeng Jinjin(Department of Neurosurgery,Beijing Children′s Hospital Affiliated to Capital Medical University,National Children′s Medical Center,Beijing 100045,China)
出处 《中华神经外科杂志》 CSCD 北大核心 2020年第5期470-475,共6页 Chinese Journal of Neurosurgery
关键词 结节性硬化症 儿童 室管膜下巨细胞星形细胞瘤 室管膜下结节 治疗结果 Tuberous sclerosis Child Subependymal giant cell astrocytoma Subependymal nodule Treatment outcome
  • 相关文献

参考文献3

二级参考文献33

  • 1Nabbout R, Santos M, Rolland Y, et al. Early diagnosis of sub?ependymal giant cell astrocytoma in children with tuberous sclerosis.J Neurol Neurosurg Psychiatry ,1999,66 :370-375. 被引量:1
  • 2Adriaensen ME, Schaefer-Prokop CM, Stijnen T, et al. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. EurJ Neurol, 2009,16: 691-696. 被引量:1
  • 3Franz DN , Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST -1 ): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet,2013 ,381: 125-132. 被引量:1
  • 4J62wiak S, Nabbout R, Curatolo P, et al. Management of sub?ependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) : Clinical recommendations. EurJ Paediatr Neurol,2013 ,17 :348-352. 被引量:1
  • 5Grajkowska W, Kotulska K,Jurkiewicz E, et al. Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas. Folia Neuropathol,2011 ,49 :39-46. 被引量:1
  • 6JozwiakJ,Jozwiak S, Skopinski P. Imunohistochemical and mic?roscopic studies on giant cells in tuberous sclerosis. Histol Histopathol,2005 ,20: 1321-1326. 被引量:1
  • 7Campen CJ, Porter BE. Subependymal giant cell astrocytoma ( SEGA) treatment update. Curr Treat Options N eurol, 2011 , 13 : 380-385. 被引量:1
  • 8Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.J Child Neurol,1998 ,13 :624-628. 被引量:1
  • 9Krueger DA, Care MM, Holland K, et al. Everolimus for sube?pendymal giant-cell astrocytomas in tuberous sclerosis. N EnglJ Med ,2010 ,363: 1801-1811. 被引量:1
  • 10de Ribaupierre S,Dorfmtiller G,Bulteau C,et al. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery ,2007,60 :83-89. 被引量:1

共引文献29

同被引文献40

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部